Clinical and Genetic Studies on Holoprosencephaly
NCT00088426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 256
Last updated 2020-04-20
Summary
This study will examine how holoprosencephaly (HPE) affects people, how they change over time, and what genes may be involved in the cause of the disorder. HPE is a defect of brain development in utero in which the forebrain fails to sufficiently divide into two hemispheres, resulting in a single-lobed brain and skull and facial malformations. In most cases, the defects are so severe that babies die before birth. There are three classifications of HPE. In alobar HPE the brain does not divide at all; this form is usually associated with severe facial deformities. In semilobar HPE the hemispheres divide somewhat, causing an intermediate form of the disorder. In lobar HPE, the mildest form, separation of hemispheres is nearly normal.
Patients with HPE and their direct blood relatives may participate in this study. Patients are seen by a team of medical specialists at the NIH Clinical Center for the following procedures:
* Physical and neurological examination
* Eye examination
* Imaging studies, such as echocardiogram, abdominal ultrasound, brain MRI
* Electroencephalogram (EEG)
* Hearing evaluation
* Blood and urine samples for genetic and endocrine studies, routine blood chemistries, urinalysis, and urine electrolytes
* Other consultations as needed
* Possibly photographs, including front and side views of the face and other body parts that may be involved in HPE, such as the eyes, teeth, hands, and feet
Parents will be asked questions about the child's prenatal, birth, newborn, and past medical history, growth, behavior and development, and therapy and medication.
Because HPE is a genetic disorder and gene changes can be passed on in a family, parents will also be asked to undergo the following procedures:
* Completion of a medical and family history form
* Physical and neurological examination
* Blood and urine samples (for mothers only)
* Specialty consultations as indicated
* Possibly photographs, including front and side views of the face and other body parts that may be involved in HPE, such as the eyes, teeth, hands, and feet
* Psychosocial study. Some parents will be asked to participate in a telephone interview or complete a questionnaire, or both, about their attitudes, beliefs, and concerns about how they and their family cope with their child's condition. Some questionnaires may include questions about aspects of their marriage and personal feelings and experiences.
Parents will meet with a doctor and a genetics nurse to discuss the results of the tests and answer questions. Parents may be asked to bring their child back to the NIH after 2 years for follow-up examination and possible additional or repeat testing.
...
Conditions
- Holoprosencephaly
- HPE
- Developmental Delay Disorders
- Brain Disorders
Sponsors & Collaborators
-
National Human Genome Research Institute (NHGRI)
lead NIH
Principal Investigators
-
Paul S Kruszka, M.D. · National Human Genome Research Institute (NHGRI)
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-23
- Primary Completion
- 2020-03-16
- Completion
- 2020-04-16
Countries
- United States
Study Locations
More Related Trials
-
Corpus Callosum Agenesis and Intellectual Disability
NCT02167568 ·Status: COMPLETED
-
Combining Exome and Transcriptome Data to Unravel the Genetic Basis of the Lissencephalies
NCT05185414 ·Status: UNKNOWN ·Phase: NA
-
Personalized Genomic Research
NCT01294345 ·Status: COMPLETED
-
Longitudinal Study of Neurogenetic Disorders
NCT03492060 ·Status: RECRUITING
-
Study of Genetic Risk Factors for Spina Bifida and Anencephaly
NCT00031122 ·Status: UNKNOWN
-
Evaluation of Patients With Unresolved Chromosome Abnormalities
NCT00001639 ·Status: COMPLETED
-
Genetic Analysis of Craniosynostosis, Philadelphia Type
NCT00367796 ·Status: COMPLETED
-
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum
NCT03600792 ·Status: COMPLETED
-
Clinical and Molecular Investigations Into Ciliopathies
NCT00068224 ·Status: COMPLETED
-
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
NCT00556530 ·Status: RECRUITING
-
Hyperekplexia in Patients With CTNNB1 Mutation
NCT05168969 ·Status: COMPLETED
-
Natural History of Craniofacial Anomalies and Developmental Growth Variants
NCT02639312 ·Status: RECRUITING
-
Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD
NCT04406636 ·Status: UNKNOWN
-
Genetic Aspects of Neurologic and Psychiatric Disorders
NCT00001544 ·Status: COMPLETED
-
MEHMO Natural History and Biomarkers
NCT06019182 ·Status: RECRUITING
-
Genetic Analysis of Craniofrontonasal Syndrome
NCT00339846 ·Status: COMPLETED
-
Genetics of Neonatal Encephalopathy and Related Disorders
NCT07165938 ·Status: RECRUITING
-
Inherited Reproductive Disorders
NCT01500447 ·Status: RECRUITING
-
Genetics and Psychopathology in the 22q11 Deletion Syndrome
NCT00161109 ·Status: UNKNOWN
-
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
NCT05354622 ·Status: RECRUITING
-
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
NCT00075348 ·Status: COMPLETED
-
Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
NCT06014541 ·Status: TERMINATED
-
Prenatal Molecular Characterisation by CGH+SNP-ARRAY of Supernumerary Marker Chromosomes and de Novo Apparently Balanced Reciprocal Translocations
NCT01907425 ·Status: TERMINATED ·Phase: NA
-
Study of Clinical and Molecular Manifestations of Genetic Disorders
NCT00001466 ·Status: COMPLETED
-
Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population
NCT00341068 ·Status: TERMINATED